EDX Medical’s annual results highlight new cancer testing services, major diagnostic partnerships and £5.5 million in funding, alongside a £5.7 million full-year loss as the group continued investing in commercial..
EDX Medical’s annual results highlight new cancer testing services, major diagnostic partnerships and £5.5 million in funding, alongside a £5.7 million full-year loss as the group continued investing in commercial growth and laboratory capabilities...
